30 related articles for article (PubMed ID: 5170743)
1. Tumor therapy of neoplastic diseases with tumor cells and neuraminidase. Further experimental studies on chessboard vaccination in canine mammary tumors.
Sedlacek HH; Hagmayer G; Seiler FR
Cancer Immunol Immunother; 1986; 23(3):192-9. PubMed ID: 3791304
[TBL] [Abstract][Full Text] [Related]
2. Characterization of rubella virus-induced hemolysis.
Kobayashi N; Suzuki M
Arch Virol; 1982; 71(2):149-54. PubMed ID: 7065903
[TBL] [Abstract][Full Text] [Related]
3. Trypsinized human group O erythrocytes as an alternative hemagglutinating agent for Japanese encephalitis virus.
Shortridge KF; Hu LY
Appl Microbiol; 1974 Apr; 27(4):653-6. PubMed ID: 4856948
[TBL] [Abstract][Full Text] [Related]
4. Letter: Trypsin-treated human erythrocytes for rubella hemagglutination inhibition tests.
Bannerman CM; Ross CA
J Clin Pathol; 1973 Oct; 26(10):807-8. PubMed ID: 4806340
[No Abstract] [Full Text] [Related]
5. Use of trypsin-modified human erythrocytes in rubella hemagglutination-inhibition testing.
Quirin EP; Nelson DB; Inhorn SL
Appl Microbiol; 1972 Sep; 24(3):353-7. PubMed ID: 4627966
[TBL] [Abstract][Full Text] [Related]
6. Agglutination of trypsinized sheep erythrocytes by the pili of Corynebacterium renale.
Honda E; Yanagawa R
Infect Immun; 1974 Dec; 10(6):1426-32. PubMed ID: 4373397
[TBL] [Abstract][Full Text] [Related]
7. Haemagglutination of trypsin modified human erythrocytes by chagres virus.
Shortridge KF
Arch Virol; 1976; 52(1-2):181-6. PubMed ID: 1033754
[No Abstract] [Full Text] [Related]
8. Rubella virus hemagglutination with human and animal erythrocytes: effect of age and trypsinization.
Ponzi AN; Pugliese A; Pertusio P
J Clin Microbiol; 1978 May; 7(5):442-7. PubMed ID: 659573
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new test system for rubella haemagglutination inhibiting antibodies.
Roberts PC; Hobbs SJ
J Clin Pathol; 1977 Nov; 30(11):1011-4. PubMed ID: 591638
[TBL] [Abstract][Full Text] [Related]
10. Virus titrations using trypsin modified erythrocytes.
Shortridge KF; Hu LY
J Clin Pathol; 1977 Oct; 30(10):993-5. PubMed ID: 591636
[No Abstract] [Full Text] [Related]
11. A non-specific agglutination problem in the rubella haemagglutination-inhibition test using trypsinised human red cells.
McCartney A
J Clin Pathol; 1979 Jan; 32(1):93. PubMed ID: 429585
[No Abstract] [Full Text] [Related]
12. The use of trypsin-treated human group O erythrocytes in rubella hemagglutination-inhibition test.
Iwakata S; Morrissey LP; Rhodes AJ; Labzoffsky NA
Arch Gesamte Virusforsch; 1974; 45(4):352-61. PubMed ID: 4474863
[No Abstract] [Full Text] [Related]
13. The use of rivanol for the removal of nonspecific inhibitors of rubella virus haemagglutinin.
Toms GL; Mostratos A
J Med Microbiol; 1973 Feb; 6(1):45-52. PubMed ID: 4347864
[No Abstract] [Full Text] [Related]
14. Serum inhibitors of A 2 -Hong Kong influenza virus haemagglutination.
Shortridge KF; Lansdell A
Microbios; 1972 Dec; 6(24):213-9. PubMed ID: 4348986
[No Abstract] [Full Text] [Related]
15. Structural studies of red cells: immunochemistry of the M,N and related antigens and of the myxoviral receptors.
Pardoe GI; Uhlenbruck G; Reifenberg U
Med Lab Technol; 1971 Jul; 28(3):255-83. PubMed ID: 4104635
[No Abstract] [Full Text] [Related]
16. Virus-erythrocyte interactions.
Howe C; Lee LT
Adv Virus Res; 1972; 17():1-50. PubMed ID: 4348510
[TBL] [Abstract][Full Text] [Related]
17. The unmasking of receptors for rubella virus by trypsinization of red cells.
Biddle F
Microbios; 1971 Apr; 3(12):255-60. PubMed ID: 5170743
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
